WATERFORD, Conn.—Retina Consultants of America (RCA), a physician management services organization, announces the addition of Retina Group of New England (RGNE) to its nationwide network of physicians. This addition is RCA’s 30th partnership and first in Connecticut, to now operate in 20 states across the U.S. “The doctors of Retina Group of New England are excited to join the ranks of highly accomplished and nationally recognized physicians and business team of RCA,” said Dr. Nauman Chaudhry, Retina Group of New England.

“We believe our partnership with RCA will significantly enhance our access to cutting edge and state of the art clinical trials and other resources in delivering the highest quality of care to our patients. Similarly, it will provide excellent opportunities for continuous growth and development of our employees and will contribute to the betterment of our community. We feel honored to be in the company of some of the national and world leaders in the field of macular and vitreoretinal disorders and look forward to working closely with them.”
Retina Group of New England specializes in the treatment of age-related macular degeneration, diabetic retinopathy, retinal detachment repair, retinal vein occlusions, and other disorders of the retina, vitreous, and macula.
D. Virgil Alfaro and Eric P. Jablon of Retina Consultants of Charleston and RCA, released a joint statement on the addition of RGNE to their network of physicians.
“Through partnership with Retina Group of New England, RCA continues its mission in advancing eyecare with practices who share a common ethos of clinical excellence and the highest quality care for the patients we serve. We have great admiration for Drs. Chaudhry and Colina and have enjoyed our academic and clinical relationship since 1993 at the Yale School of Medicine. Having worked on multiple academic projects and publications throughout the years, we could not be more thrilled to welcome our friends to the RCA family.”
RCA’s business model enables retina specialists to retain autonomy and ownership, augmented by sharing best practices facilitated through the medical leadership board and executive management support. Practices within the network will continue to drive all clinical decisions and remain highly involved in strategic operations.